
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10374271
[patent_doc_number] => 20150259278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS'
[patent_app_type] => utility
[patent_app_number] => 14/432183
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16153
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432183
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432183 | CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS | Sep 25, 2013 | Abandoned |
Array
(
[id] => 10387921
[patent_doc_number] => 20150272928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'INDOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/431574
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26033
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431574
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431574 | INDOLE DERIVATIVES | Sep 25, 2013 | Abandoned |
Array
(
[id] => 11263217
[patent_doc_number] => 09487505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them'
[patent_app_type] => utility
[patent_app_number] => 14/037026
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40961
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14037026
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/037026 | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them | Sep 24, 2013 | Issued |
Array
(
[id] => 9269899
[patent_doc_number] => 20140024817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'CRYSTAL OF SPIROKETAL DERIVATIVES AND PROCESS FOR PREPARATION OF SPIROKETAL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/034880
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18740
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034880
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034880 | Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives | Sep 23, 2013 | Issued |
Array
(
[id] => 9223776
[patent_doc_number] => 20140018551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'HYDROGENATION OF CATMINT OIL'
[patent_app_type] => utility
[patent_app_number] => 14/034857
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7149
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034857
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034857 | Hydrogenation of catmint oil | Sep 23, 2013 | Issued |
Array
(
[id] => 10347435
[patent_doc_number] => 20150232440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'COUMARIN DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/429300
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10495
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429300 | Coumarin derivative | Sep 19, 2013 | Issued |
Array
(
[id] => 9971384
[patent_doc_number] => 09018396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Modified carbocyanine dyes and their conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/030835
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26513
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030835 | Modified carbocyanine dyes and their conjugates | Sep 17, 2013 | Issued |
Array
(
[id] => 9212798
[patent_doc_number] => 20140011975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'CLEANING DEVICE FOR SEPARATING DILACTIDE FROM MIXTURES, POLYMERISATION DEVICE, METHOD FOR SEPARATING DILACTIDE FROM MIXTURES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/026050
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7420
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14026050
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/026050 | Cleaning device for separating dilactide from mixtures, polymerisation device, method for separating dilactide from mixtures and use thereof | Sep 12, 2013 | Issued |
Array
(
[id] => 11236545
[patent_doc_number] => 09463177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Compounds and methods for modulating vascular injury'
[patent_app_type] => utility
[patent_app_number] => 14/426341
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 22
[patent_no_of_words] => 22902
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426341
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426341 | Compounds and methods for modulating vascular injury | Sep 8, 2013 | Issued |
Array
(
[id] => 10325661
[patent_doc_number] => 20150210665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES'
[patent_app_type] => utility
[patent_app_number] => 14/426305
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14321
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426305
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426305 | Organocatalytic process for asymmetric synthesis of decanolides | Sep 5, 2013 | Issued |
Array
(
[id] => 9422688
[patent_doc_number] => 20140107339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES'
[patent_app_type] => utility
[patent_app_number] => 14/017803
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12453
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/017803 | Substituted 3-hydroxy-δ-lactones from epoxides | Sep 3, 2013 | Issued |
Array
(
[id] => 11176853
[patent_doc_number] => 09408829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Inhibitors of CD40-TRAF6 interaction'
[patent_app_type] => utility
[patent_app_number] => 14/417708
[patent_app_country] => US
[patent_app_date] => 2013-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 21
[patent_no_of_words] => 6938
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417708 | Inhibitors of CD40-TRAF6 interaction | Aug 26, 2013 | Issued |
Array
(
[id] => 9463252
[patent_doc_number] => 20140127679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Chemical probe compounds that become fluorescent upon reduction, and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 13/975675
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6517
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13975675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/975675 | Chemical probe compounds that become fluorescent upon reduction, and methods for their use | Aug 25, 2013 | Issued |
Array
(
[id] => 10838241
[patent_doc_number] => 08865918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Androgen receptor modulator compounds and methods'
[patent_app_type] => utility
[patent_app_number] => 13/974937
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40988
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974937
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/974937 | Androgen receptor modulator compounds and methods | Aug 22, 2013 | Issued |
Array
(
[id] => 11809046
[patent_doc_number] => 09713603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis'
[patent_app_type] => utility
[patent_app_number] => 14/422642
[patent_app_country] => US
[patent_app_date] => 2013-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 6281
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422642 | Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis | Aug 19, 2013 | Issued |
Array
(
[id] => 9199064
[patent_doc_number] => 20130338379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN'
[patent_app_type] => utility
[patent_app_number] => 13/970373
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4481
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970373 | PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN | Aug 18, 2013 | Abandoned |
Array
(
[id] => 10318497
[patent_doc_number] => 20150203500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'TRIS(HETERO)ARYLPYRAZOLES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/422191
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25900
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422191
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422191 | Tris(hetero)arylpyrazoles and use thereof | Aug 15, 2013 | Issued |
Array
(
[id] => 9896212
[patent_doc_number] => 20150051410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS'
[patent_app_type] => utility
[patent_app_number] => 13/967473
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27008
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967473
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967473 | Processes and intermediates for the preparations of isomer free prostaglandins | Aug 14, 2013 | Issued |
Array
(
[id] => 9370983
[patent_doc_number] => 20140080856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/965691
[patent_app_country] => US
[patent_app_date] => 2013-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16827
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965691
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/965691 | Crystalline forms of an 8-azabicyclo[3.2.1]octane compound | Aug 12, 2013 | Issued |
Array
(
[id] => 11772445
[patent_doc_number] => 09381195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Derivatives of azaindazole or diazaindazole type for treating pain'
[patent_app_type] => utility
[patent_app_number] => 14/417507
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 50324
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417507 | Derivatives of azaindazole or diazaindazole type for treating pain | Jul 28, 2013 | Issued |